
The Stem Cell Podcast
A podcast dedicated to culturing knowledge in stem cell research. Brought to you by STEMCELL Technologies.
Latest episodes

Apr 7, 2020 • 1h 26min
Ep. 165: “Tackling Heart Disease” Featuring Dr. Deepak Srivastava
Dr. Deepak Srivastava is the President of the Gladstone Institutes and the International Society for Stem Cell Research, and the co-founder of Tenaya Therapeutics. His lab investigates the gene networks that guide cardiogenesis by developing models of heart disease using patient-derived iPSCs and CRISPR technology.

Mar 24, 2020 • 1h 1min
Ep. 164: “iPSCs and Highly Endangered Species” Featuring Dr. Jeanne Loring
Dr. Jeanne Loring is a Professor Emeritus and Director of the Center for Regenerative Medicine at the Scripps Research Institute, and the co-founder of Aspen Neuroscience. Her lab works on a diverse range of projects using iPSCs, including developing cell replacement therapies for Parkinson’s disease, sending neural organoids into space, and partnering with the San Diego zoo to make iPSCs from engangered species.

Mar 10, 2020 • 1h 2min
Ep. 163: “Bone Tissue Regeneration” Featuring Dr. Joy Wu
Dr. Joy Wu is an Associate Professor of Medicine at Stanford University, and a a board-certified endocrinologist. With both basic and translational research, her lab studies stem cell therapies for bone formation and the prevention of cancer metastases to bone, as well as the bone marrow hematopoietic niche.

Feb 25, 2020 • 1h 11min
Ep. 162: “The Human Fetal Retina” Featuring Dr. Thomas Reh
Dr. Thomas Reh is a Professor of Biological Structure at the University of Washington School of Medicine. His research is aimed at stimulating more effective regeneration in the retina to restore vision in people that have lost their sight.

Feb 11, 2020 • 1h 15min
Ep. 161: “Generation of Functional and Mature Beta Cells” Featuring Priye Iworima
Priye Iworima is a PhD student at the University of British Columbia. Her project is focused on developing and optimizing a differentiation protocol for generating insulin-producing cells derived from stem cells that could be used as a potential therapy for type 1 diabetes.

Jan 28, 2020 • 1h 7min
Ep. 160: “Engineering Human Cardiac Muscle” Featuring Dr. Kacey Ronaldson-Bouchard
Dr. Kacey Ronaldson-Bouchard is an Associate Research Scientist at Columbia University focusing on biomedical engineering. She is also the co-founder of TARA Biosystems, which offers physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications.

Jan 14, 2020 • 1h 38min
Ep. 159: “Stem Cell Patterning by Automated Design” Featuring Dr. Todd McDevitt
Dr. Todd McDevitt is a Senior Investigator at the Gladstone Institutes and a Program Director and Professor at UCSF. His research focuses on engineering 3D, multicellular systems that can be used to study principles of stem cell and developmental biology.

Dec 24, 2019 • 1h 22min
Ep. 158: “Science Communication in Industry” Featuring Dr. Nicole Quinn
Dr. Nicole Quinn is the Associate Director of Scientific Communications at STEMCELL Technologies, and one of the people hard at work behind the scenes of the Stem Cell Podcast. After completing her PhD in genomics and discovering her love of communicating science, Nicole left the bench to pursue a science communications career in the biotech industry.

Dec 10, 2019 • 1h 1min
Ep. 157: “Secrets of Hematopoiesis” Featuring Dr. Camilla Forsberg
Dr. Camilla Forsberg is the Co-Director of the Institute for the Biology of Stem Cells, and a Professor of Biomolecular Engineering at the University of California, Santa Cruz. Her lab seeks to understand the molecular determinants of hematopoietic stem cell fate decisions.

Nov 26, 2019 • 1h 6min
Ep. 156: “Engineering the Stem Cell Niche” Featuring Dr. Peter Zandstra
Dr. Peter Zandstra is the Director of the School of Biomedical Engineering at the University of British Columbia. His lab applyies engineering design principles, computational modeling, and fundamental stem cell biology to study the mechanisms that control stem cell fate, and to develop technologies for the propagation of stem cells and their derivatives.